Form 4 Tracker
Crinetics Pharmaceuticals, Inc.
CRNX

23 insider filings · Latest: Aug 7, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 10, 2024Sep 10 4:11 PMBetz Stephen F.
Proposed Sale
1,035$51.50$53.3K

View →

Aug 26, 2024Aug 26 5:16 PMBetz Stephen F.
Proposed Sale
3,000$53.19$159.6K

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 7, 2026Aug 11 8:11 PMStruthers Richard ScottDirector, President & CEO
Option Exercise
19,928$25.19244,205(D)

View →

Jun 18, 2026Jun 22 9:09 PMCaren DeardorfDirector
Grant/Award
9,730$35.879,730(D)

View →

Jun 18, 2026Jun 22 9:05 PMMatthew K FustDirector
Grant/Award
9,730$35.879,730(D)

View →

Jun 18, 2026Jun 22 9:04 PMWeston NicholsDirector
Grant/Award
9,730$35.879,730(D)

View →

Jun 18, 2026Jun 22 9:03 PMCoelho Rogerio VivaldiDirector
Grant/Award
9,730$35.879,730(D)

View →

Jun 18, 2026Jun 22 9:02 PMCamille L BedrosianDirector
Grant/Award
9,730$35.879,730(D)

View →

Jun 18, 2026Jun 22 9:01 PMWendell WierengaDirector
Grant/Award
9,730$35.879,730(D)

View →

Jun 18, 2026Jun 22 9:00 PMStephanie OkeyDirector
Grant/Award
9,730$35.879,730(D)

View →

Apr 8, 2026Apr 10 8:33 PMJeff E. KnightChief Dev. & Operating Officer
Option Exercise
78,434$23.9865,977(D)

View →

Feb 23, 2026Feb 25 9:37 PMStruthers Richard ScottDirector, President & CEO
Grant/Award
228,000$43.79228,000(D)

View →

Feb 23, 2026Feb 25 9:36 PMTobin SchilkeChief Financial Officer
Grant/Award
50,000$43.7950,000(D)

View →

Feb 23, 2026Feb 25 9:34 PMJeff E. KnightChief Operating Officer
Grant/Award
55,000$43.7955,000(D)

View →

Feb 23, 2026Feb 25 9:34 PMStephen F. BetzChief Scientific Officer
Grant/Award
47,000$43.7947,000(D)

View →

Feb 23, 2026Feb 25 9:32 PMIsabel KalofonosChief Commercial Officer
Grant/Award
55,000$43.7955,000(D)

View →